Login
Oncology Education
 
Register new Account
Recover Password
NAVIGATION
  • Home
  • About Us
  • Tumour Sites
    • Breast
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • GI
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Lung
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • GU
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Head & Neck
      • Videos
      • Podcasts
    • Hematology
      • Videos
      • Slides
      • Podcasts
    • Melanoma
      • Videos
      • Slides
      • Podcasts
    • Gynecology
      • Videos
      • Slides
      • Podcasts
      • Key Journal Articles
    • Global Cancer Control
      • Videos
      • Podcasts
    • Other Topics
      • Videos
      • Slides
      • Podcasts
  • Resources
    • Events
    • OE Event Videos
    • Cancer Congress Coverage
    • Speaker Spotlight
    • Podcasts
    • Trainee Resources
    • E-Learning Portal
    • Best of Oncology Weekly
    • Job Postings
    • Cancer and Aging
  • COVID-19 Resources
  • Login/Account
    • Register new Account
    • Recover Password
    • Login
    • Contact Us
  • Search
  • home
  • Tumour Sites
  • Other Topics
  • Videos

Recent Videos

Lunch Symposium (Mylan) - The Future of Biosimilars in Oncology - Implementing the Lessons from Today

Featuring:
Dr. Stephen Chia

GI - Colorectal and Non-Colorectal

Featuring:
Dr. Stephanie Snow

Radiation Oncology Update: Management of Oligometastases

Featuring:
Dr. Alexander Louie

Updates and Optimizing Outcomes in Non Intensive AML Management

Featuring:
Dr. Jorge Cortes
Chair:
Dr. Brian Leber

Optimizing Patient Outcomes for HER2+ Early Breast Cancer

Featuring:
Dr. Anil Joy
Dr. Olexiy Aseyev
Dr. Angel Arnaout
Alia Thawer
Chair:
Dr. Sonal Gandhi

Critical Role of Treating Minimal Residual Disease in Acute Lymphoblastic Leukemia

Featuring:
Dr. Nikola Gokbuget
Chair:
Dr. Andre Schuh

A Decade of Systemic Treatments of Hepatocellular Carcinoma: From a Myth to a Central Role

Featuring:
Dr. Ghassan Abou-Alfa
Chair:
Dr. Sharlene Gill

Drug development in Immuno-Oncology

Featuring:
Dr. Jason Luke

Biomarkers in Immuno-Oncology

Featuring:
Dr. Rosalyn Juergens

Cellular Therapies: Clinical Overview

Featuring:
Dr. Michael Chu

Cellular Therapies: Production and Challenges

Featuring:
Dr. Brad Nelson

Cellular Therapies: Q&A

Featuring:
Dr. Michael Chu and Dr. Brad Nelso

GI - Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

Common Adverse-Events

Featuring:
Dr. Ralph Wong

Uncommon Adverse-Events

Featuring:
Dr. Jose Monzon

Implementation of Biosimilars in Clinical Practice: Cost, Ethics, and Nuances

Featuring:
Dr. Scott Berry
Dr. Christine Brezden-Masley
Dr. Stephen Chia
Dr. John Hilton
Dr. Scott Edwards
Swanee Tobin

The evolving treatment landscape of advanced cSCC

Featuring:
Dr. Teresa Petrella
Chair:
Dr. Gary Groot

Defining the Standard of Care in NSCLC

Featuring:
Dr. Marina Garassino
Dr. Randeep Sangha

CheckMate 649, ATTRACTION-4, KEYNOTE-062, KEYNOTE-590 and CheckMate 577

Gastroesophageal Cancer
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 and PRODIGE 13

GI Colorectal
Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Disparities in Cancer during the COVID-19 Pandemic: CCOS Study

Featuring:
Dr. Sheena Bhalla

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

Impact of COVID-19 on management of cancer treatments & psychological consequence for patients

Featuring:
Dr. Florence Joly

KEYNOTE-590 Study

Featuring:
Dr. Ken Kato

CheckMate 577 Study

Featuring:
Dr. Ronan Kelly

CheckMate 649 study

Featuring:
Dr. Markus Moehler

Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection (COVID-19 Data)

Featuring:
Dr. Trisha Wise-Draper

HAIC with FOLFOX vs. TACE for unresectable HCC

Featuring:
Dr. Ming Shi

The Canadian Cancer Trials Group PA.7 Trial

Featuring:
Dr. Daniel Renouf

Clinical & lab prognostic factors in patients with cancer and SARS-CoV-2 infection: CCC19

Featuring:
Dr. Petros Grivas

The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLAA

Featuring:
Dr. Pia Kvistborg

KEYNOTE-177 Study

Featuring:
Dr. Thierry André

The Impact of COVID-19 on Oncology Professionals: Initial Results of The ESMO Resilience Task Force Survey Collaboration

Featuring:
Dr Susana Banerjee

Outcome and prognostic factors of SARS CoV-2 infection in cancer patients

Featuring:
Dr. Markus Joerger

ESMO 2020 Virtual Data Watch - GI

Application of Biosimilars in Clinical Care: Potential Opportunities and Barriers

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Sandeep Sehdev

Debate: What is the optimal endpoint in adjuvant lung cancer trials evaluating target treatments?

Featuring:
Dr. Roy Herbst &
Dr. Jack West
Chair:
Dr. Frances Shepherd

Understanding the Approach to Managing Skin Toxicities Associated with Managing mCRC

Featuring:
Dr. Mario Lacouture
Chair:
Dr. Nathan Lamond

Real World Experience in the EU with Biosimilars

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Bruce Colwell

Panel Discussion: Does the Primary Matter? - Moving Towards a Tumour-Agnostic Approach

Featuring:
Dr. Gwyn Bebb
Dr. Stephen Yip
Dr. Janessa Laskin

Cancer Care in COVID-19 Era

Featuring:
Dr. Sharlene Gill

Colorectal GI Cancer

Featuring:
Dr. Jonathan Loree

Non-Colorectal GI Cancer

Featuring:
Dr. Patricia Tang

Supportive Care

Featuring:
Dr. Elie Kassouf

Practice Changing Data

Featuring:
Dr. Kim Ma

Non-Colorectal GI Cancer

Featuring:
Dr. Frédéric Lemay

Colorectal GI Cancer

Featuring:
Dr. Petr Kavan

The Cancer and the Virus: How to Treat One While Keeping the Other One at Bay - The Quebec Strategy

Featuring:
Dr. Jamil Asselah

Does treatment sequencing matter in metastatic colorectal cancer?

Featuring:
Dr. Julien Taieb
Chair:
Dr. Scott Berry

Lunch Symposium - Update on Treatments for Advanced RCC: Making Choices Using Script Concordance Theory

Featuring:
Dr. Aly-Khan Lalani

Canadian Achievements in Cancer Research

Featuring:
Dr. Natasha Leighl
Dr. Stephen Chia

Colorectal GI Cancers

Featuring:
Dr. Sharlene Gill

Non-Colorectal GI Cancers

Featuring:
Dr. Grainne O'kane

CodeBreak 100 & Prevalence of KRASG12C Mutations Utilizing ctCDA

KRAS G12C Mutations

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

KEYNOTE-177 & Pembrolizumab Monotherapy in MSI-H Pts

MSI-H Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

NTRK-FP Solid Tumors - Integrated Analysis & Larotrectinib in Pts with TRK Fusion

NTRK Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

BLU-667 in RET Fusion+ Solid Tumors

RET Fusion+ Solid Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

DESTINY-CRC01

Her-2 Positive Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

PETRARCA, NRG/RTOG 1010 & RAMSES/FLOT7

Periporative/Neoadjuvant Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

SWOG S1505 & ESPAC 5F

Pancreatic Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

DESTINY-Gastric01

Metastatic Gastroesophageal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

RAPIDO, UNICANCER PRODIGE 23 & OPRA

Rectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-177 & PANDA

Metastatic Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

IDEA, CALGB/SWOG 80702 & JCOG0603

Adjuvant Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

MEDETREME Trial

Featuring:
Dr. Francois Ghiringhelli

ASCO20 Virtual Data Watch: GI Cancers

Esophago-Gastric Cancer

Featuring:
Dr. Elena Elimova

Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty

Colorectal Cancer

Featuring:
Dr. Scott Berry

Case-Based Presentation in GI Cancers

Featuring:
Dr. Suneil Khanna

GI Faculty Panel Discussion and Q&A

Featuring:
Dr. Scott Berry
Dr. Mark Doherty
Dr. Yoo-Joung Ko
Dr. Suneil Khanna

GI Colorectal and Non-Colorectal

Featuring:
Dr. Sharlene Gill

Sequoia Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

GemCis +/- Veliparib in BRCA mutated Pancreatic CA

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

KEYNOTE-158 Study

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

JCOG 1007 Study (IPACS)

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Javelin Gastric 100 Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Beacon CRC Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Expel Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Halo 109-301 Trial

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

Patient Reported Outcomes From Imbrave 150

Featuring:
Dr. Scott Berry,
Dr. Marc Peeters
Dr. Daniel Renouf

GI Colorectal and Non-Colorectal Cancer Update

Featuring:
Dr. Mike Vickers

Breakfast Symposium: HCC

Featuring:
Dr. Yoo-Joung Ko

Q+A and Case Presentation

Featuring:
Dr. David Hogan and Dr. Adrian Sacher

NTRK: A Transformative New Paradigm in Oncology

Featuring:
Dr. David Hogan

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel,Q&A

Featuring:
Dr. Parneet Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Patient Monitoring/Patient Tools

Featuring:
Massey Nematollahi

Immune Related Complications From Immune Checkpoint Inhibitors - Dermatologic

Featuring:
Dr. Tom Salopek

Immune Related Complications From Immune Checkpoint Inhibitors - Hepatitis

Featuring:
Dr. Morven Cunningham

Immune Related Complications From Immune Checkpoint Inhibitors - Neurologic

Featuring:
Dr. Dubravka Dodig

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel, Q&A

Featuring:
Dr. Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Rhematologic

Featuring:
Dr. Raman Joshi

Immune Related Complications From Immune Checkpoint Inhibitors - Nephritis

Featuring:
Dr. Gabrielle Cote

Immune Related Complications From Immune Checkpoint Inhibitors - Pneumonitis

Featuring:
Dr. Shane Shapera

Immune Related Complications From Immune Checkpoint Inhibitors - Diarrhea/Colitis

Featuring:
Dr. Nazira Chatur

Clinical Evidence For Immune-therapies In Practice - Cases Discussion Panel, Q&A

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - Breast Cancers

Featuring:
Dr. Dave Cescon

Clinical Evidence For Immune-therapies In Practice - Melanoma

Featuring:
Dr. Scott Ernst

Clinical Evidence For Immune-therapies In Practice - Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - GI Cancers

Featuring:
Dr. Suneil Khanna

Clinical Evidence For Immune-therapies In Practice - GU Cancers

Featuring:
Dr. Nazanin Fallah-Rad

Principles of Immunotherapeutic Strategies

Featuring:
Dr. Linh Nguyen

The Future of Precision Medicine

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Phase I Study of AMG 510

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract 528PD: Correlative analysis of CCTG CO.26

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract LBA30_PR: Correlative analysis of IDEA-FRANCE phase III trial

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract: LBA15_PR

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

TRK Fusion Updates

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Circulating Tumour DNA Trials

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ANGEL study

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

KEYNOTE-062

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

BEACON Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ClarIDHy Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

ATTRACTION-3 Study

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

CheckMate 459 Trial

Featuring:
Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick

Delays to Systemic therapy and impact to therapy

Featuring:
Dr. Brandon Meyers

TKI toxicity and dose modifications

Featuring:
Dr. Vincent Tam

Treatment Paradigm

Featuring:
Dr. Peter Metrakos

Therapeutic drug monitoring of oral anticancer drugs

Featuring:
Dr. Steffie Groenland
Dr. Neeltje Steeghs

Durvalumab activity in previously treated patients

Featuring:
Dr. Siddharth Sheth

ClarIDHy Study

Featuring:
Dr. Ghassan Abou-Alfa

MAGE-A4 Trial

Featuring:
Dr. Brian Van Tine

KEYNOTE-062 Trial

Featuring:
Dr. Kohei Shitara

FIGHT-202 Study

Featuring:
Dr. Arndt Vogel

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

Sarcoma

Featuring:
Dr. Christine Simmons

Colorectal GI Cancer

Featuring:
Dr. Hagen Kennecke

Non-Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Novel Immune Therapy Approaches: From Immune Checkpoint Inhibitors to Adoptive T-Cell Transfer

Featuring:
Dr. Michael Smylie

Non-Colorectal GI Cancer

Featuring:
Dr. Christine Brezden-Masley

Colorectal GI Cancer

Featuring:
Dr. Mark Doherty

Canadian Achievements in Cancer Research

Featuring:
Dr. Mark Clemons

Canadian Achievements in Cancer Research

Featuring:
Dr. Lisa Barbera

Evidence For NTRK Inhibitors

Featuring:
Dr. David Hong & Dr. Adrian Sacher

Supportive Care

Featuring:
Dr. Elie Kassouf

New Technologies in Cancer Care

Featuring:
Dr. John Kildea

Colorectal and Non Colorectal GI Cancer

Featuring:
Dr. Benoit Samson

IDEA Study (High Risk Stage 2 Patients)

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Foxtrot Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ABC-06

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Polo Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

Apact Trial

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Broad Indications for Immunotherapy

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

Trials of Oxaliplatin-based Therapy 3 vs. 6 months in Colorectal Cancer

Featuring:
Dr. Tim Iveson

Namodenoson in Patients with Child-Pugh B HCC

Featuring:
Dr. Salomon Stemmer

End of Life Quality at Minority-Serving Cancer Centers

Featuring:
Dr. Garrett Wasp

NRG-GI002 Study

Featuring:
Dr. Thomas George

Monteluksat and Rupatadine and their combination with Rituximab

Featuring:
Dr. Rouslan Kotchetkov

Routine ESAS use on OS

Featuring:
Dr. Lisa Barbera

Foxtrot Study

Featuring:
Dr. Dion Morton

What is the Role of 'Big Data' in Cancer Care

Featuring:
Cindy Perettie, CEO, Foundation Medicine Inc.

Panel Discussion

Future of Precision Medicine

Featuring:
Dr. Trevor Pugh

The Impact of Artificial Intelligence and 'Big Data' on Health Policy

Featuring:
Dr. Catherine Stinson

BioInformatics and the Role of Artificial Intelligence in Cancer Care

Featuring:
Dr. Benjamin Haibe-Kains

How is Technology Impacting Drug Development in Oncology

Featuring:
Dr. Leigh Revers

Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Keynote Lecture: Newer Advances in the Treatment of Late Stage MCRC

Featuring:
Dr. Michael Morse

Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Case-Based Presentations In GI Cancers

Featuring:
Dr. Suneil Khanna

Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty 

Colorectal Cancer

Featuring:
Dr. Ron Burkes

Lunch Presentation - Biosimilars in Oncology

Featuring:
Dr. Anil Abraham Joy
Dr. Sandeep Sehdev

GI Colorectal

Featuring:
Dr. Patricia Tang

GI Non-Colorectal

Featuring:
Dr. Sharlene Gill

Special Session: Best of Real World Evidence in Oncology

Featuring:
Dr. Winson Cheung

Best of Oncology East 2018

November 30th, 2018
Toronto, ON

Satellite Symposium - Lunch Presentation - Chemotherapy-Induced Nausea and Vomiting — A Case-Based Presentation

Featuring: Dr. Kasia Jerzak
Shikha Lawrence

Best of Oncology East 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Suneil Khanna

Best of Oncology East 2018 - Colorectal GI Cancer

Featuring:
Dr. Scott Berry

Pain Management & Holistic Care

Featuring:
Dr. Martin Chasen
Dr. Scott Berry

Steatorrhea, Pancreatic Enzyme Insufficiency, & Diagnosing Diabetes

Featuring:
Dr. Michael Sawyer
Jessica Kasnik

Comorbidities and Concomitant Use of Medications

Featuring:
Dr. Tim Asmis
Lisa Rambout

Diabetic Patient Considerations and Neuropathy Management

Featuring:
Dr. Tim Asmis
Lisa Rambout

Biomarkers to Guide Treatment Decision: PDL-1 and Beyond

Featuring:
Dr. Ming Tsao

CAR T-Cell Therapy: Are we driving in the fast lane?

Featuring:
Dr. Christine Chen

Innovating Clinical Trial Designs to accelerate Immune-Therapies in Cancer 

Featuring:
Dr. Martin Smoragiewicz

Combination Strategies to Enhance Efficacy 

Featuring:
Dr. Adrian Sacher

Panel Discussion 

Featuring:
Dr. Martin Smoragiewicz
Dr. Christine Chen
Dr. Adrian Sacher

The Future of IO Therapies Beyond Checkpoint Inhibitors

Featuring:
Dr. Rosalyn Juergens

Panel Discussion 

Featuring:
Dr. Natasha Leighl
Dr. Henry Conter
Dr. Sunil Verma

The Canadian Advantage – Role of Real World Evidence and Opportunities to Enhance Value of IO Therapies in Canada 

Featuring:
Dr. Natasha Leighl

Case Studies and Panel Discussion 

Featuring:
Dr. Andrew Robinson
Dr. Nancy Nixon
Dr. David Hogg
Dr. Teresa Petrella

Role of Multi-Disciplinary Team in Management of Patients on IO Therapies

Featuring:
Dr. David Hogg

Keynote Lecture: Personalizing Immune-Therapies and Understanding resistance 

Featuring:
Dr. David Carbone

Canadian Immuno-Oncology Summit 2018

November 1st, 2018
Toronto, ON

Atezo + Bev in HCC

Featuring:
Dr Michael Pishvaian

TAGs Trial

Featuring:
Dr. Hendrik Tobias Arkenau

Initial of BMS-986158 in Phase 1 dose escalation

Featuring:
Dr. John Hilton

PHOENIX Study

Featuring:
Dr. Ali Alkan

AMC303

Featuring:
Dr. Emiliano Calvo

Probiotics in Chemo-induced Diarrhea

Featuring:
Dr. Atul Sharma

MODUL Study - Updates in Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

TRIBE 2 Study - Updates in Unresectable Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

TAGS Study - Updates in Metastatic Gastric Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

NIVO + IPI 1L - Updates in Metastatic Colorectal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

InterAACT Study - Updates in Anal Cancer

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

Updates in Biliary Tract Cancer 

Featuring:
Dr Scott Berry
Dr Sharlene Gill
Dr Marc Peeters

KEYNOTE-181 study

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

The COMPASS Trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

Treatment BRAF V600E–mutated biliary tract cancer: a cohort of the ROAR basket trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

CCTG CO.26 trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

The COLOPEC Trial

Featuring:
Dr. Daniel Renouf
Dr. Scott Berry
Dr. Sharlene Gill

NIVO + IPI 1L IN MSI-H/DMMR MCRC

Featuring:
Dr. Heinz-Josef Lenz

NETSARC Study

Featuring:
Dr. Jean-Yves Blay

Panel Discussion 

Featuring:
Dr. David Carbone
Dr. Rosalyn Juergens
Dr. Teresa Petrella
Dr. Ming Tsao
Dr. Sunil Verma

Cost of integrating Immuno-Oncology Therapy in Clinical Practice: Are we prepared?

Featuring:
Dr. Henry Conter

Best of ASCO Vancouver 2018 - Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Best of ASCO Vancouver 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Vincent Tam

Special Session: Precision Oncology

Featuring:
Dr. Gwyn Bebb

Lunch Symposium - New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw and Roland Coppens

Best of ASCO Toronto 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Elena Elimova

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw & Mark Pasetka

Canadian Achievements in Cancer Research, PRODIGE 24

Featuring:
Dr. Jim Biagi

Best of ASCO Toronto 2018 - Colorectal GI Cancer

Featuring:
Dr. Scott Berry

Best of ASCO Montreal 2018 - GI Cancers (Non-Colorectal and Colorectal)

Featuring:
Dr. Frederic Lemay

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Nathaniel Bouganim and Veronique Savard

Best of ASCO Montreal 2018 - Supportive Care

Featuring:
Dr. Elie Kassouf

Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

PIVOT Trial

Featuring:
Dr. Adi Diab

Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

MATCH Study

Featuring:
Dr. Young Kwang Chae

PRODIGE 24/PA.6 TRIAL - Updates in Pancreatic Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

PRODIGE 7 - Updates in Colorectal Cancer & Isolated Peritoneal Metastases

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ECOG 7208 Study - Updates in Advanced Colorectal Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

ADORE Trial - Updates in Resected Rectal Cancer

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

REACH2 STUDY - Updates in Hepatocelluar Carcinoma

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

KEYNOTE-061 trial

Featuring:
Dr. Charles Fuchs

PRODIGE 24/CCTG PA.6 Trial

Featuring:
Dr. Jim Biagi

Duplicate of Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

Duplicate of HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

Duplicate of PIVOT Trial

Featuring:
Dr. Adi Diab

Duplicate of Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

Duplicate of MATCH Study

Featuring:
Dr. Young Kwang Chae

Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Updates in Pancreatic Neuroendocrine Tumours

Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Duplicate of Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Panel Discussion on Biosimilars

Featuring:
Dr. Scott Berry
Flay Charbonneau
Alexandra Chambers
Dr. Andrea Eisen
Dr. Hal Hirte
Dr. Sunil Verma
Dr. Sandy Sehdev
Barry Stein

From Bench to Bedside with Bevacizumab Biosimilars

Featuring:
Dr. Scott Berry

Biosimilars in Breast Cancer: Clinical Implications

Featuring:
Dr. Sunil Verma

Update from CADTH on Biosimilars

Featuring:
Alexandra Chambers
‎Director, pan Canadian Oncology Drug Review (pCODR), CADTH

Understanding the Science of Biosimilars: How are they different from emerging drugs? What are they and how are they created?

Featuring:
Dr. Sandy Sehdev

Best of GUGI 2018 - Pancreatic Cancer

Featuring:
Dr. Yoo-Joung Ko

Best of GUGI 2018 - Esophago-Gastro Cancer

Featuring:
Dr. Elena Elimova

Best of GUGI 2018 - Hepatobiliary Cancer

Featuring:
Dr. Mark Doherty

Best of GUGI 2018 - Colorectal Cancer

Featuring:
Dr. Rachel Goodwin

Best of Oncology East 2017 - Colorectal GI Cancer

Featuring:
Dr. Ronald Burkes

Best of Oncology East 2017 - Non-Colorectal GI Cancer

Featuring:
Dr. Elena Elimova

Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -3 months

Featuring:
Dr. Jeff Myers

Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -6 months

Featuring:
Dr. Robert El-Maraghi

Video 1: Introduction to Biosimilars

Video 4: Biosimilars in Clinical Practice Panel Discussion

Featuring:
Dr. Scott Berry
Dr. Sunil Verma
Dr. Sandy Sehdev

Video 3: Bevacizumab Biosimilars Clinical Considerations

Featuring:
Dr. Scott Berry

Video 2: Trastuzumab Biosimilars Clinical Considerations

Featuring:
Dr. Sunil Verma

Best of Oncology West 2018 - Colorectal GI Cancer

Featuring:
Dr. Sharlene Gill

Best of Oncology West 2018 - Non-Colorectal GI Cancer

Featuring:
Dr. Daniel Renouf

Special Session - Biosimilars

Featuring:
Dr. Sunil Verma

RAINFALL Trial: Chemotherapy With or Without Ramicirumab for Untreated Metastatic Gastric Cancer

Featuring: Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

FUGA-BT Trial: Gemcitabine plus S-1 vs Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

Celestial Trial: Cabozantinib vs Placebo in Sorafenib Resistant Hepatocellular Carcinoma

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

Update on Checkmate 142

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Sharlene Gill

From Bench to Bedside: Translating New Knowledge to Drug Development

Featuring:
Dr. Linh Nguyen

From Bedside to Bench – Understanding Immune-Therapy Resistance

Featuring:
Dr. Jason Luke

Biomarkers to Guide IO Therapy

Featuring:
Dr. Rosalyn Juergens

PD-L1 Testing in Routine Practice

Featuring:
Dr. Ming Tsao

Management of Immune-Therapy Related Adverse Events

Featuring:
Dr. David Hogg

Utilizing Immuno-Oncology Therapies in Clinical Practice

Featuring:
Dr. Michael Smylie

Beyond Checkpoint Inhibitors – Novel IO Therapies and IO-IO Combination Therapy

Featuring:
Dr. Jason Luke

IO Combination with Chemotherapy, Radiation and Targeted Therapies

Featuring:
Dr. Heather McArthur

Video 1: Advanced in Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

Video 2: Advanced in Non-Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Sharlene Gill
Dr. Marc Peeters

JACOB Study: Pertuzumab in the 1st Line Treatment of HER2+ Metastatic Gastric Cancer

Featuring:
Dr. Scott Berry

PRODIGE 18 Study

Featuring:
Dr. Jaafar Bennouna

KEYNOTE-028 Study

Featuring:
Dr. Janice Mehnert

VOLFI Trial of the AIO(AIO-KRK0109)

Featuring:
Dr. Michael Geissler

German AIO KRK0110 (ML22011) Study

Featuring:
Dr. Dominik Modest

Denosumab in Giant Cell Tumor of Bone

Featuring:
Dr. Emanuela Palmerini

Nivolumab & ISA 101 HPV vaccine in incurable HPV-16+ cancer

Featuring:
Dr. Erminia Massarelli

Antivascular Tumour Therapy

Featuring:
Dr. Urban Emmenegger

Molecular Targeting and Drug Design

Featuring:
Dr. Aaron Schimmer

Updates in Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Hagen Kennecke
Dr. Marc Peeters

Updates in Non-Colorectal Cancer

Featuring:
Dr. Scott Berry
Dr. Hagen Kennecke
Dr. Marc Peeters

Case 1: Adjuvant Therapy

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 2: Metastatic Disease - First Line Options (Overview)

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 3: Metastatic Disease - First Line Options (Older Patients and Patients with Poorer PS)

Featuring:
Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Case 4: Treating Metastatic Disease with Gemcitabine and Nab-Paclitaxel (Hyperbilirubinemia and A/E Management)

Featuring: Dr. Scott Berry
Dr. Ramesh Ramanathan
Dr. Robert El-Maraghi

Alliance Trial: American Cancer Society Nutrition & Physical Activity Guidelines

Featuring:
Dr. Erin Van Blarigan

SCOT Study: Final DFS Results

Featuring:
Dr. Timothy Iveson

SIRveNIB Trial

Featuring:
Dr. Pierce Chow

CALGB / SWOG 80405 (ALLIANCE) - Association of Mutations With OS

Featuring:
Dr. Federico Innocenti

METIVHCC Trial

Featuring:
Dr. Lorenza Rimassa

FLOT4-AIO Trial

Featuring:
Dr. Scott Berry

CALGB / SWOG 80405 (Alliance) - Prognostic Value of Primary Tumor Location

Featuring:
Alan P. Venook

IDEA Trial Summary

Featuring:
Dr. Ron Burkes

SWOG 21406 Trial 2

Featuring:
Dr. Scott Kopetz

Updates from Chicago 2017: Other Topics

June 3-7, 2017
Chicago, USA

Breakfast Symposium

Gastric Cancer in 2016 - The important Role of Nutrition

Featuring:
Dr. Christine Brezden-Masley
Denise Gabrielson

Best of GUGI 2017 - Pancreatic Cancer

Featuring:
Dr. Yooj Ko

Best of GUGI 2017 - Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Best of GUGI 2017 - Colon Cancer

Featuring:
Dr. Scott Berry

Best of GUGI 2017 - Hepatobiliary Cancer

Featuring:
Dr. Jennifer Knox

Best of ASCO Toronto 2017 - GI Colorectal Cancer

Featuring:
Dr. Ronald Burkes

Best of ASCO Toronto 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Mark Doherty

Canadian Achievements in Cancer Research

Featuring:
Dr. Monika Kryzyzanowska

Canadian Achievements in Cancer Research

Featuring:
Sierra Cheng

Best of ASCO Montreal 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Isabelle Gingras

Best of ASCO Montreal 2017 - Canadian Abstracts

Featuring:
Dr. Kim Ma

Health Sciences Research: Patient Reported Outcomes

Featuring:
Dr. Robert Olson

Best of ASCO Vancouver 2017 - GI Colorectal Cancer

Featuring:
Dr. Scot Dowden

Best of ASCO Vancouver 2017 - GI Non-Colorectal Cancer

Featuring:
Dr. Sharlene Gill

Left vs Right-Sided Colorectal Tumours - Does Location of the Primary Impact Clinical Practice?

Featuring:
Dr. Marc Peeters
Dr. Rachel Goodwin, Chair

Best of Oncology West 2016 - GI Colorectal

Featuring:
Dr. Sharlene Gill

Best of Oncology West 2016 - GI Non-Colorectal

Featuring:
Dr. Christina Kim

Debate - Medical Assistance in Dying

Featuring:
Dr. Charles Blanke
Dr. Howard Lim

Highlights from 2017 ASCO GI Symposium

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Winson Cheung
Dr. Mustapha Tehfe

2016 Pancreatic Cancer Year in Review

Featuring:
Dr. Scott Berry
Dr. Daniel Renouf
Dr. Winson Cheung
Dr. Mustapha Tehfe

Debate on Second Entry Biologic

Featuring:
PRO: Dr. Leigh Revers
CON: Dr. Sandy Sehdev

Best of Oncology East 2016 - GI Colorectal Cancer

Featuring:
Dr. Ronald Burkes

Best of Oncology East 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Yoo-Joung Ko

Promises and Challenges in Immuno-Oncology

Featuring:
Dr. Réjean Lapointe

Innovative Approaches to the Management of Pancreatic Cancer

Featuring:
Dr. Philip Philip

Treatment and Management Considerations in Advanced Pancreatic Cancer

Featuring:
Dr. Philip Philip

Resectable Pancreatic Cancer and Beyond_The Role of Neoadjuvant and Adjuvant Therapies

Featuring:
Dr. Philip Philip

Emerging Evidence in Localized Disease Management

Featuring:
Dr. Philip Philip

The Future - Targeted Therapies for the Treatment of Pancreatic Adenocarcinoma

Featuring:
Dr. Philip Philip

Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (English)

Featuring:
Dr. Simron Singh
Dr. Rachel Goodwin

Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (French)

Featuring:
Dr. Simron Singh
Dr. Rachel Goodwin

Principles of Immuno-Oncology - A Clinician Perspective

Featuring:
Dr. Omid Hamid

Round Table Discussion: Colorectal Cancer Highlights from ESMO 2016

Featuring:
Dr. Scott Berry
Dr. Scot Dowden
Dr. Hagen Kennecke

LUME-Colon 1 Study

Featuring:
Dr. Scott Berry

GI Non-Colorectal Cancer Highlights

Featuring:
Dr. Tim Asmis

MCBS in rare tumor entities

Featuring:
Dr. Barbara Kiesewetter

CCTG/AGITG CO.23 Trial

Featuring:
Dr. Derek Jonker

The FACS Randomized Clinical Trial

Featuring:
Dr. John Primrose

Dabrafenib, Trametinib, and Panitumumab in BRAF V600E–Mutated mCRC

Featuring:
Dr. Ryan Corcoran

NGS Identifies Distinct Molecular Signatures of HER2 Inhibition

Featuring:
Dr. Yelena Janjigian

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors

Featuring:
Dr. Catharina Menke-van der Houven van Oordt

BAY 1163877

Featuring:
Dr. Markus Joerger

CheckMate-040 Study

Featuring:
Dr. Ignacio Melero

PRIME-NET study

Featuring:
Dr. Sara Pusceddu

Tumour gene expression data and clinical decision-making for patients with advanced cancers

Featuring:
Dr. Janessa Laskin

Trabectedin vs best supportive care in pretreated advanced soft tissue sarcoma

Featuring:
Dr. Axel Le Cesne

GOLD Study

Featuring:
Dr. Yung Bang

Lunch Symposium: Urothelial Cancers Management

Featuring:
Dr. Robert Dreicer

Round-Table Discussion on Pharmacoeconomics

Featuring:
Dr. Kathleen Barnard, Dr. Brent Fraser, Dr. Jaclyn Beca, Dr. Marcus Butler & Dr. Ilias Illiopolous
Chair: Dr. Sunil Verma

Keynote Presentation: Future Applications in Immuno-Oncology

Featuring:
Dr. Jason Luke

A New Way of Treating: Multidisciplinary Approach in Immuno-Therapy

Featuring:
Dr. David Hogg

Panel Discussion: Redefining Success in Oncology

Featuring:
Dr. Jason Luke, Kathleen Barnard, Christina Sit & Dr. Marcus Butler
Moderator: Dr. Rosalyn Juergens

Plenary Session Q&A

Featuring:
Dr. Jason Luke, Kathleen Barnard, Dr. Marcus Butler & Dr. Linh Nguyen
Chair: Dr. Sunil Verma

Immuno-Oncology: From Concept to Reality

Featuring:
Dr. Jason Luke

Beyond the Curve

Featuring:
Kathleen Barnard

Principles of Immuno-Oncology - An Immunologist Perspective

Featuring:
Dr. Linh Nguyen

Lorazepam as an Adjuvant to Haloperidol for Agitated Delirium at the End of Life

Featuring:
Dr. David Hui

CALM Trial

Featuring:
Dr. Gary Rodin

Psychological Intervention on the Fear of Cancer

Featuring:
Dr. Jane Beith

Korean Red Ginseng to Improve Cancer-Related Fatigue

Featuring:
Dr. Yeul Hong Kim

Immune response, safety, and survival impact in soft tissue sarcomas

Featuring:
Dr. Neeta Somaiah

Laboratory Methods in Translational Oncology Research

Featuring:
Dr. Kelsie Thu

Keynote Address: The Important Molecular/ Translational Endpoints In Clinical Trials

Featuring:
Dr. Kathy Pritchard

DNA Repair and Epigenetics

Featuring:
Dr. Rosalyn Juergens

Oncogenes/Tumour Suppressor Genes

Featuring:
Dr. Neesha Dhani

Signaling Pathways

Featuring:
Dr. Tony Mutsaers

Cell Cycle and Survival Mechanisms

Featuring:
Dr. David Cescon

Stem Cells

Featuring:
Dr. Catherine O'Brien

Tumour Immunobiology/ Immunotherapy

Featuring:
Dr. Marcus Butler

Invasion Metastasis

Featuring:
Dr. Richard Hill

Molecular Pathology

Featuring:
Dr. Ming Tsao

An Introduction to Biomarkers

Featuring:
Dr. Phil Bedard

Molecular Pharmacology/ Epidemiology

Featuring:
Dr. Geoff Liu

Webinar Archive: ASCO 2016 Updates

Key GI Cancer Trials

Featuring:
Dr. Scott Berry

Best of ASCO Vancouver 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Sharlene Gill

Best of ASCO Vancouver 2016 - GI Colorectal Cancer

Featuring:
Dr. Scot Dowden

Circulating Tumour DNA to Reshape the Design of Clinical Trials

Featuring:
Dr. Jeanne Tie

Canadian Achievements in Cancer Research

Featuring:
Dr. Kathy Pritchard

Best of ASCO Toronto 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Rachel Goodwin

Best of ASCO Toronto 2016 - GI Colorectal Cancer

Featuring:
Dr. Ron Burkes

Best of ASCO Montreal 2016 - Neuroendocrine Cancers

Featuring:
Dr. Simron Singh

Best of ASCO Montreal 2016 - GI Non-Colorectal Cancer

Featuring:
Dr. Thierry Alcindor

Best of ASCO Montreal 2016 - GI Colorectal Cancer

Featuring:
Dr. Scott Berry

Highlights on Cancer and the Heart ASCO 2016

Featuring:
Dr. Susan Dent

CALGB 80802 (NCIC HEC 1) & ESPAC-4 Updates

Featuring:
Dr. Vincent Tam

Phase I study of sapacitabine and seliciclib

Featuring:
Dr. Sara Tolaney

Comorbidities & Risk of Peripheral Neuropathy in SWOG Trials

Featuring:
Dr. Dawn Hershman

Phase 1B Study of BGJ398 with BYL719

Featuring:
Dr. David Hyman

ESPAC-4 Trial

Featuring:
Dr. John Neoptolemos

NETTER-1 Study

Featuring:
Dr. Jonathan Strosberg

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy

Featuring:
Dr. Ian Kleckner

CREST Study

Featuring:
Dr. James Hill

Analysis of CALGB/SWOG 80405 (Alliance)

Featuring:
Dr. Alan Venook

Precision Medicine in Cancer Care

Featuring:
Dr. Jonathan Trent

Gastric Cancer in Ontario

Featuring:
Dr. Natalie Coburn

Systemic Therapy for Metastatic Gastric Cancer

Featuring:
Dr. Scott Berry

The Future of Stage IV Gastric Cancer Management

Featuring:
Dr. Han-Kwang Yang

Panel Discussion: Cancer Care in 2025

Featuring:
Dr. Scott Berry

Perspective from BC Cancer Agency

Featuring:
Dr. Malcolm Moore

Perspective from Lung Cancer Canada

Featuring:
Dr. Paul Wheatley-Price

Perspective from Colorectal Cancer Association of Canada

Featuring:
Mr. Barry Stein

Perspective from CAMO

Featuring:
Dr. Christopher Lee

Perspective from CARO

Featuring:
Dr. Gerard Morton

Perspective from CSSO

Featuring:
Dr. Jay Engel

Perspective from Innovative Medicines Canada

Featuring:
Mr. Marc Zarenda

Best of GUGI 2016 - Pancreatic Cancers

Featuring:
Dr. Daniel Renouf

Best of GUGI 2016 - Esophago-Gastro and Colorectal Cancer

Featuring:
Dr. Scot Dowden

Best of GUGI 2016 - Esophago-Gastro Cancer

Featuring:
Dr. Christine Brezden-Masley

Webinar Archive: NETs Speaker Tour Montreal

Featuring:
Dr. Simron Singh

NETs Case Study

Featuring:
Dr. Petr Kavan

NETs in Québec

Featuring:
Dr. Albert Moghrabi

What's New with NETs?

Featuring:
Dr. Simron Singh

Best of Oncology West 2017 - Supportive Care

Featuring:
Dr. Corey Metcalf

Best of Oncology West 2017 - GI Non-Colorectal Cancers

Featuring:
Dr. Daniel Renouf

Best of Oncology West 2017 - GI Colorectal Cancer

Featuring:
Dr. Patricia Tang

Dinner Symposium: The Management of Metastatic Gastric Cancer

Featuring:
Dr. Sharlene Gill
Dr. Emile Woo
Dr. Howard Lim

Webinar Archive: NETs Speaker Tour Vancouver

Featuring:
Dr. Simron Singh
Dr. John Paul McGhie
Dr. Hagen Kennecke

NET Case Study

Featuring:
Dr. Hagen Kennecke

BC Perspective on NETs

Featuring:
Dr. John Paul McGhie

What's New With NETs?

Featuring:
Dr. Simron Singh

Webinar Archive: NETs Speaker Tour Toronto

Featuring:
Dr. Simron Singh
Dr. Calvin Law
Dr. Tim Asmis

Neuroendocrine Cancers: What's New With NETs?

Featuring:
Dr. Simron Singh

Advanced NETs

Featuring:
Dr. Calvin Law

Non-Functioning Small pNETS

Featuring:
Dr. Tim Asmis

Popular Videos

Updates from Chicago 2017: Other Topics

June 3-7, 2017
Chicago, USA

Best of Oncology East 2018

November 30th, 2018
Toronto, ON

Canadian Immuno-Oncology Summit 2018

November 1st, 2018
Toronto, ON

Webinar Archive: NETs Speaker Tour Montreal

Featuring:
Dr. Simron Singh

Webinar Archive: NETs Speaker Tour Toronto

Featuring:
Dr. Simron Singh
Dr. Calvin Law
Dr. Tim Asmis

Webinar Archive: NETs Speaker Tour Vancouver

Featuring:
Dr. Simron Singh
Dr. John Paul McGhie
Dr. Hagen Kennecke

Perspective from BC Cancer Agency

Featuring:
Dr. Malcolm Moore

Oncogenes/Tumour Suppressor Genes

Featuring:
Dr. Neesha Dhani

Optimizing Patient Outcomes for HER2+ Early Breast Cancer

Featuring:
Dr. Anil Joy
Dr. Olexiy Aseyev
Dr. Angel Arnaout
Alia Thawer
Chair:
Dr. Sonal Gandhi

Real World Experience in the EU with Biosimilars

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Bruce Colwell

Defining the Standard of Care in NSCLC

Featuring:
Dr. Marina Garassino
Dr. Randeep Sangha

Debate: What is the optimal endpoint in adjuvant lung cancer trials evaluating target treatments?

Featuring:
Dr. Roy Herbst &
Dr. Jack West
Chair:
Dr. Frances Shepherd

A Decade of Systemic Treatments of Hepatocellular Carcinoma: From a Myth to a Central Role

Featuring:
Dr. Ghassan Abou-Alfa
Chair:
Dr. Sharlene Gill

Application of Biosimilars in Clinical Care: Potential Opportunities and Barriers

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Sandeep Sehdev

Broad Indications for Immunotherapy

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

The evolving treatment landscape of advanced cSCC

Featuring:
Dr. Teresa Petrella
Chair:
Dr. Gary Groot

Routine ESAS use on OS

Featuring:
Dr. Lisa Barbera

FIGHT-202 Study

Featuring:
Dr. Arndt Vogel

Implementation of Biosimilars in Clinical Practice: Cost, Ethics, and Nuances

Featuring:
Dr. Scott Berry
Dr. Christine Brezden-Masley
Dr. Stephen Chia
Dr. John Hilton
Dr. Scott Edwards
Swanee Tobin

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

Lunch Presentation - Biosimilars in Oncology

Featuring:
Dr. Anil Abraham Joy
Dr. Sandeep Sehdev

Immune Related Complications From Immune Checkpoint Inhibitors - Pneumonitis

Featuring:
Dr. Shane Shapera

Clinical Evidence For Immune-therapies In Practice - Breast Cancers

Featuring:
Dr. Dave Cescon

Clinical Evidence For Immune-therapies In Practice - GI Cancers

Featuring:
Dr. Suneil Khanna

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

DISCLAIMER: The educational materials and other information which are accessible on this website (the “Information”) have been expertly curated for, and are intended exclusively for the consumption and use by, Health Care Practitioners (“Qualified Practitioner(s)”) or professionals working in the Oncology industry . The Information is not intended for consumption, access or use by the general public, including patients, unless such a user is a Qualified Practitioner. You acknowledge and agree that your use of this website will at all times be in full compliance with the website Terms of Use.

  • Breast Cancer
  • Lung Cancer
  • GI Cancer
  • GU Cancer
  • Head and Neck
  • Hematology
  • Melanoma
  • Gynecology
  • Global Cancer Control
  • Other Topics
  • Upcoming Events
  • Trainee Resources
  • E-Learning Portal
  • Best of Oncology Weekly
  • About Us
  • Faculty
  • Contact Us
  • Site Policies
  • Job Postings
  • Cancer and Aging
© Copyright 2021 Oncology Education, site by: BigBlock Studios